Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody

Catalog No. ABIN7597566

This Chimeric Chimeric antibody specifically detects TNFRSF8 (Brentuximab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant TNFRSF8 (Brentuximab Biosimilar) antibody (ABIN7597566)

Target: TNFRSF8 (Brentuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This TNFRSF8 (Brentuximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-TNFRSF8 (Brentuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Brentuximab Biosimilar Antibody

Specificity: CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for TNFRSF8 (Brentuximab Biosimilar)

Target: TNFRSF8 (Brentuximab Biosimilar)

Alternative Name: Brentuximab Biosimilar

Target Type: Biosimilar

Background: CD30L receptor, Ki-1 antigen, CD30, TNFRSF8, D1S166E, Tumor necrosis factor receptor superfamily member 8, Lymphocyte activation antigen CD30

UniProt: P28908

CAS-No: 914088-09-8